Back
Amplify Treatments, Testing and Adv ETF 10K Form
Buy
59
GERM
Amplify Treatments, Testing and Adv ETF
Last Price:
19.06
Seasonality Move:
10.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GERM News And Ratings
See the #1 stock for the next 7 days that we like better than GERM
GERM Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Amplify Treatments, Testing and Adv ETF Earnings Forecast
Key Amplify Treatments, Testing and Adv ETF Financial Ratios
Amplify Treatments, Testing and Adv ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | GERM |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GERM Technical Analysis vs Fundamental Analysis
Buy
59
Amplify Treatments, Testing and Adv ETF (GERM)
is a Buy
Is Amplify Treatments, Testing and Adv ETF a Buy or a Sell?
-
Amplify Treatments, Testing and Adv ETF stock is rated a Buy
The current Amplify Treatments, Testing and Adv ETF [GERM] share price is $19.23. The Score for GERM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.